The The Role of Pharmacists in Pharmaceutical Services and Care for Menopausal Women: A Narrative Review
Main Article Content
Abstract
Menopause is an anticipated physiological change in women marked by the end of the menstrual cycle, The complexity of its symptoms requires comprehensive and multidisciplinary interventions, including support from pharmacists. This article aims to review the pharmacist’s function in pharmaceutical care for menopausal women. The analysis was conducted narratively, highlighting key themes related to pharmacists' understanding of hormone replacement therapy (HRT) and non-pharmacological interventions, the types of pharmaceutical services provided, and challenges in practice implementation. Based on literatures obtained, it is indicated that pharmacists play a crucial function in education, counseling, therapy monitoring, and promoting a healthy lifestyle for menopausal women. Pharmacist involvement has been shown to improve patient knowledge, therapy adherence, treatment efficacy, and the prevention of long-term complications such as diabetes, osteoporosis, and cardiovascular disease. However, challenges such as limited knowledge, lack of training, limited consultation privacy, and low patient awareness of the pharmacist's role remain. In conclusion, strengthening the role of pharmacists in pharmaceutical care for menopausal women is crucial for improving patients' quality of life, and further research is needed to develop more innovative and sustainable intervention models.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright and grant the journal the right of first publication simultaneously under the Creative Commons Attribution License. This license allows others to share the work with proper acknowledgment of authorship and initial publication in this journal. Authors are permitted and encouraged to deposit their articles in institutional repositories, on their personal websites, or in other online repositories after the article has been published in JSFK.
References
[1] Davis SR, Pinkerton J, Santoro N, Simoncini T. Menopause—Biology, consequences, supportive care, and therapeutic options. Cell. 2023 Sep;186(19):4038–58. https://doi.org/10.1016/j.cell.2023.08.016
[2] Maniapoto T, Young A, Smith A. Providing over-the-counter vaginal oestrogen in New Zealand a cross-sectional study of pharmacists’ views. Journal of Primary Health Care. 2025. https://doi.org/10.1071/HC25065
[3] Hickey M, LaCroix AZ, Doust J, Mishra GD, Sivakami M, Garlick D, et al. An empowerment model for managing menopause. The Lancet. 2024 Mar;403(10430):947–57. https://doi.org/10.1016/ S0140-6736(23)02799-X
[4] Chow H, Righton O, Berry H, Bell Z, Flynn A. A systematic review of community pharmacy interventions to improve peri- and post-menopausal health. Post Reprod Health. 2024 Mar;30(1):55–63. https://doi.org/10.1177/20533691231223681
[5] Brown L, Hunter MS, Chen R, Crandall CJ, Gordon JL, Mishra GD, et al. Promoting good mental health over the menopause transition. The Lancet. 2024 Mar;403(10430):969–83. https://doi.org/10.1016/ S0140-6736(23)02801-5
[6] Thavabalan K, Ovenell A, Pierce P, Sutaria A, Parkhouse A, Baydemir N, et al. Barriers to the safe discussion of the experience and management of menopausal symptoms: A systematic literature review. Maturitas. 2025 Oct;201:108683. https://doi.org/10.1016/j.maturitas.2025.108683
[7] Brand-Eubanks D, Winter AM, Buchman CR, Hughes JA. A Call to Action for Examining Perimenopause and Menopause Education in Doctor of Pharmacy Curricula. American Journal of Pharmaceutical Education. 2025 Jun;89(6):101411. https://doi.org/10.1016/j.ajpe.2025.101411
[8] Elmahjoubi E, Rghebi N, Benamer W, Yamane M. Are there Opportunities for a Specialist Menopause Pharmacist in Libya?. AlQalam Journal of Medical and Applied Sciences. 2021; 4(1):107-115. https://doi.org/10.5281/zenodo.4514686
[9] Barner JC, Branvold A. Patients’ willingness to pay for pharmacist-provided menopause and hormone replacement therapy consultations. Research in Social and Administrative Pharmacy. 2005 Mar;1(1):77–100. https://doi.org/10.1016/j.sapharm.2004.12.008
[10] McNamara A. Women’s Health: Issues and Opportunities for Managed Care Pharmacy. JMCP. 2001 Jul;7(4):263–7.
[11] Comparetto C, Borruto F. Treatments and Management of Menopausal Symptoms: Current Status and Future Challenges. OBM Geriatr. 2023 Sep 13;07(03):1–47. https://dx.doi.org/10.21926/obm.geriatr.2303248
[12] Ambikairajah A, Walsh E, Cherbuin N. A review of menopause nomenclature. Reprod Health. 2022 Dec;19(1):29. https://doi.org/10.1186/s12978-022-01336-7
[13] Barber K, Charles A. Barriers to Accessing Effective Treatment and Support for Menopausal Symptoms: A Qualitative Study Capturing the Behaviours, Beliefs and Experiences of Key Stakeholders. PPA. 2023 Nov;Volume 17:2971–80. https://doi.org/10.2147/PPA.S430203
[14] Karlsson Lind L, Von Euler M, Korkmaz S, Schenck-Gustafsson K. Sex differences in drugs: the development of a comprehensive knowledge base to improve gender awareness prescribing. Biol Sex Differ. 2017 Dec;8(1):32.
[15] Putman B, Coucke L, Vanoverschelde A, Mehuys E, Lahousse L. Community pharmacist counseling improves adherence and asthma control: a nationwide study. BMC Health Serv Res. 2022 Dec;22(1):112. https://doi.org/10.1186/s12913-022-07518-0
[16] Tadesse YB, Sendekie AK, Mekonnen BA, Denberu FG, Kassaw AT. Pharmacists’ Medication Counseling Practices and Knowledge and Satisfaction of Patients With an Outpatient Hospital Pharmacy Service. INQUIRY. 2023 Jan;60:00469580231219457. https://doi.org/10.1177/00469580231219457
[17] Lu M, Zhou Y, Wang B, Hu Z, Du Y, Liu S, et al. Impact of multidisciplinary collaborative pharmaceutical care on knowledge, adherence, and efficacy of hormone therapy in climacteric women. PPA. 2018 Jul;Volume 12:1273–8. https://doi.org/10.2147/PPA.S165238
[18] Mansour D, Barber K, Chalk G, Noble N, Digpal AAS, Talaulikar V, et al. The evolving perspective of menopause management in the United Kingdom. Womens Health (Lond Engl). 2024 Jan;20:17455057241288641. https://doi.org/10.1177/17455057241288641
[19] Shepherd JE. Pharmacy-Based Care for Perimenopausal and Postmenopausal Women. Journal of American Pharmaceutical Association. 2002. 42 (5): 700-712
[20] Kakkar V, Kaur D, Kaur IP. Positive influence of counseling in relieving menopausal symptoms. 2012; International Journal of Comprehensice Pharmacy. 2012. 4(3)
[21] Tanna NK, Pitkin J, Anderson C. Development of the specialist menopause pharmacist (SMP) role within a research framework. Pharm World Sci. 2005 Feb;27(1):61–7. https://doi.org/10.1007/s11096-004-1730-5
[22] Whitfield, K., Clavarino, A. Women’s health from a pharmacy perspective, In Babar, Z. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. . 2023. Springer Nature. Switzerland. 1317-1335. https://link.springer.com/10.1007/978-3-030-64477-2
[23] Lai PSM, Chua SS, Chan SP. Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis. Int J Clin Pharm. 2013 Aug;35(4):629–37. https://doi.org/10.1007/s11096-013-9784-x